MedPath

Emergent BioSolutions’ ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication

Emergent BioSolutions' ACAM2000 vaccine approved by FDA for mpox prevention in high-risk individuals, based on safety data and animal study efficacy.


Reference News

Emergent BioSolutions’ ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication

Emergent BioSolutions' ACAM2000 vaccine approved by FDA for mpox prevention in high-risk individuals, based on safety data and animal study efficacy.

© Copyright 2025. All Rights Reserved by MedPath